EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PYXS: Pyxis Oncology Inc

12 Nov 25 14:32
LAST:

4.380

CHANGE:
 0.19		OPEN:
4.520		HIGH:
4.540		ASK:
0.000		VOLUME:
742.0K
CHG(%):
4.16		PREV:
4.570		LOW:
4.180		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 254.5204.5404.1804.380742.0K
11 Nov 254.7804.8004.5004.570828.3K
10 Nov 253.9604.7903.9604.7701.8M
07 Nov 254.0204.0303.7203.910562.1K
06 Nov 253.9104.1503.8804.040405.6K
05 Nov 253.9904.0203.8303.910787.1K
04 Nov 253.8404.1703.6003.9001.24M
03 Nov 253.4804.1503.4803.8101.77M
31 Oct 253.4203.7003.3323.560612.8K
30 Oct 253.3003.4403.2803.420330.6K

COMPANY PROFILE

Name:Pyxis Oncology Inc
About:Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients with several cancer indications, which is in Phase 2 clinical trial for the treatment of tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and pancreatic ductal adenocarcinoma. It has in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates, including micvotabart pelidotin and PYX-203, and other ADC product candidates directed to the licensed targets; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:321 Harrison Avenue, Boston, MA, United States, 02118
Website:https://www.pyxisoncology.com
CUSIP:747324101
CIK:0001782223
ISIN:US7473241013
FIGI:BBG00PQFFCV5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.89 
Forward P/E:-3.23 
PEG Ratio:-0.84 
Price to Sales:84.45 
Price to Book:2.72 
Profit Margin:0.97 
Operating Margin:-6.76 
Return on Assets:-0.31 
Return on Equity:-0.75 
EPS Ratio:-1.59 
Revenue:2.82M 
Shares:62.02M 
Market Cap:271.64M 

TECHNICAL INDICATORS

MA5:4.340.8%
MA10:4.038.6%
MA20:3.7317.4%
MA50:2.9249.8%
MA100:2.06113.1%
MA200:1.61172.2%
STO9:70.16
STO14:75.17
RSI14:72.73 
WPR14:-23.29
MTM14:0.97
ROC14:0.28 
ATR:0.36 
Week High:4.809.6%
Week Low:3.7217.7%
Month High:4.809.6%
Month Low:3.15172.2%
Year High:4.8711.2%
Year Low:0.83425.7%
Volatility:98.98